Background {#Sec1}
==========

Asthma is a chronic allergic respiratory disease with a heterogeneous background involving both genetic and environmental factors. In 2016, 339.4 million people worldwide were affected by asthma \[[@CR1]\]. In China, the prevalence of asthma was 3.02% in children under 14 years old (95%CI:2.97--3.06%) \[[@CR2]\]. Corticosteroids therapy can relieve the symptoms of asthma, however, the prevalence of asthma still increased significantly over the past 20 years \[[@CR3], [@CR4]\]. Exposure to all ergens in the pollutants is one of the major risk factors of asthma in children \[[@CR5]\]. Evidence currently available has shown that many environmental factors, including allergens, airborne irritants, unfavorable weather conditions and adverse indoor environment, are associated with asthma progression \[[@CR6], [@CR7]\]. Inhalable particulate matter (PM) including PM~2.5~ and PM~10~ (inhalable particles with an aerodynamic diameter less than or equal to 2.5 μm and 10 μm, respectively), is known as major environmental hazardous factors that impact human health \[[@CR8]--[@CR11]\]. Previous epidemiological studies have shown that high concentrations of PM~2.5~ and PM~10~ are associated with elevated mortality rate and increased incidence of many diseases, such as respiratory diseases, cardiovascular diseases, central nervous system diseases and inflammation \[[@CR12]--[@CR14]\]. In China, PM has become a major cause of air pollution due to rapid industrialization and urbanization in recent years \[[@CR15], [@CR16]\]. This fact leads to growing concerns on the part of hospitals, government and the public about the health risks associated with PM. In particular, the ability of stakeholders to predict the impact of PM on public health is essential for hospitals to take timely and efficient actions to handle overwhelming outpatient volume caused by hazardous environmental conditions.

Most of the studies conducted worldwide addressed the relationship between PM exposure and asthma in terms of long-term effects and few assessed the impact of PM exposure on asthma control rate \[[@CR17]\].Many studies address the transient effect of indoor and ambient pollutants and allergens on asthma exacerbation but less is known for particulate matters \[[@CR18], [@CR19]\]. On the other hand, current empirical studies examining the toxic effects of PM exposure were mostly conducted in cell lines and mouse models based on case-control design. Real world evidence derived from electronic health record (EHR) is likely to provide more pragmatic and accurate estimate of the effects of PM exposure \[[@CR20], [@CR21]\].

It has been well documented that PM exposure causes specific immune responses in the airway \[[@CR22]--[@CR24]\]. PM induces inflammation, apoptosis, increased secretion of T-cell cytokines, and DNA damage \[[@CR25], [@CR26]\]. Asthmatic symptoms are documented in 14% of children worldwide \[[@CR27]\]. Children are more susceptible to PM-related diseases because of higher breathing rates, narrower airways, immature lung tissue, and longer exposure time to outdoor ambient air \[[@CR28], [@CR29]\].

Xiamen is located on the southeast coast of China. The city is in typical subtropical climate zone. No study is available to address the short-term effects of PM on childhood asthma exacerbation and control rate in this area. Considering the increasing PM pollution in this area and growing public health concern over PM, there is a need to obtain further epidemiological evidences for public health service to take proper preventive measure to control the risk caused by PM exposure. Therefore,we designed this study to evaluate the effects of PM exposure on childhood asthma exacerbation and control rate.

Methods {#Sec2}
=======

Patient data {#Sec3}
------------

Childhood asthma data were collected from the electronic health record system of Pediatric Outpatient Department of the First Affiliated Hospital of Xiamen University (Joint Commission International accredited hospital). All subjects are outpatients between zero and 14-year-old, who were diagnosed with asthma exacerbation inthe period from January 1, 2016 to June 30, 2018.The diagnosis of childhood asthma is based on respiratory symptoms including wheezing, shortness of breath, chest tightness or cough (Additional file [1](#MOESM1){ref-type="media"} Table 1). Patients with respiratory symptoms caused by other diseases were excluded. The classification of asthmafollowsthe International Classification of Disease 10 (ICD-10-CM) code of J45 \[[@CR27]\]. The study was designed conforming to the ethical guidance (KY2015--027). For each case of acute exacerbation, the date of the latest asthma exacerbation was determined. Patients whose symptoms reappeared within 14 days were defined as the same one exacerbation, and the last exacerbation was selected as index exacerbation.

For asthma control, the outcome was determined upon return visit after four-week treatment since the initial visit based on Guidelines forthe Diagnosis and Treatment of Childhood Bronchial Asthma \[[@CR30]\]. The outcome of the disease is defined for children aged below and above six separately (Additional file [1](#MOESM1){ref-type="media"} Table 2). We further classify the cohort in to two subgroups, well-controlled asthma and uncontrolled or partly controlled asthma \[[@CR31], [@CR32]\]. Asthma was managed with budesonide aerosol inhalation, fluticasone MDI with spacerdevices, or budesonide or budesonide/formoterol powder in halation according to patients' age. The patients were followed up every oneto three months. In case of acute exacerbation, salbutamol aerosol or budesonide and aerosolized terbutaline solution for inhalation were added. Appropriate treatment was added if there was comorbidity, such as allergic rhinitis or infection. The outcome of asthma was assessed according to "Guidelines for the Diagnosis and Prevention of Asthma in Children" \[[@CR30]\]. Disease control was rated as well controlled, partly controlled, or uncontrolled according to the daytime and night symptoms inthe past 4 weeks.

Air pollution data {#Sec4}
------------------

Air pollution data were obtained from Xiamen Department of Environmental Protection. The concentration of pollutants was measured at different sites of the city. Daily average PM~10~ and PM~2.5~ concentrations were used to measure the exposure. Meteorological data including daily average ambient temperature,wind speed, cumulative precipitation, humidity and barometric pressure were obtained from Xiamen Meteorological Bureau.

Statistical analysis {#Sec5}
--------------------

Case-Crossover (CCO) designwas used to assess the effects of PM on asthma exacerbation. To measure the exposure to PM, we recorded the number of days of AQI (air quality index) level 2 or 3(24-h average of PM~2.5~ \> 35 μg/m^3^ and PM~10~ \> 50 μg/m^3^) \[[@CR33]\] within two weeks preceding the onset of the index exacerbation(Fig. [1](#Fig1){ref-type="fig"}a). We also measured the four-week-exposure before the time point of control evaluation for rating disease control. The outcome of disease control was defined as 1 if asthma was controlled, or 0 if the disease was partly controlled or uncontrolled(Fig. [1](#Fig1){ref-type="fig"}b).Fig. 1Schematic view of the study design. Panel (**a**):For patients of acute exacerbation, the day two weeks before the exacerbation was considered as control. The PM exposures within 2 weeks before the exacerbation day and control day were recorded,respectively. Panel (**b**):The PM exposure within 4 weeks before the return visitwas recorded. Patients were assessed at follow-up visit based on the symptoms in the past 4 weeks

To evaluate the effects of PM exposure on asthma exacerbation and control rate, mixed effects logistic regression was performed,in which PM exposure was considered as a fixed effect and individual patient as random effects. Fever and weather conditions including average temperature, cumulative precipitation and average wind speed were covariates in the model. We standardized the estimated odds ratio (OR) for each fixed effect to compare the effects of different factors.
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As there is high collinearity between PM~10~ and PM~2.5~, which is evidenced by pairwise Pearson correlation coefficient of 0.906, which would lead to instability in effect estimates in multivariate regression analysis, the regression models were built with the two air pollutants separately.

All statistical procedures were conducted using R-3.5.

Results {#Sec6}
=======

Summary of patient information {#Sec7}
------------------------------

A total of 3106 patients with 4728 cases of acute asthma exacerbation were identified from 16,355 cases of childhood asthma (Table [1](#Tab1){ref-type="table"}). The patients included 2110 (67.9%) males and 996 females (32.1%). The age of these patients ranged from zero to fourteen years old. Patients aged four to six accounted for the largest proportion (39.9%), showing that preschool children were affected by asthma mostly. In the control period, 53 patients (1.1%) in the study had fever and during the 2 weeks before exacerbation there were 832 patients (18.2%) who had fever. Among the 3443 returning-visit patients, 2292 (66.6%) were males and 1151 (33.4%) were females, and children aged four to six accounted for the largest proportion (44.8%). In the course of the 4 weeks in which we assessed the control level of the patients, 6.6% of the patients had fever. There are nine subtypes of J45 present in the cohort (Additional file [2](#MOESM2){ref-type="media"} Figure 1a). Bronchial asthma (J45.903) makes the majority of the cohort (41.2%), followed by asthmatic bronchitis (J45.901, 26.2%) and cough variant asthma (J45.005, 19.7%). The other subtypes (J45.004, J45.900, J45.000, J45.904, J45.006 and J45.003) cover 12.9% of the cohort.Table 1Patients' characteristics of the study cohortsNumberPercentageGenderMale211067.90Female99632.10Age(years)0--3123039.604--6123839.907--1463820.50Total3106100Return visitGenderMale229266.60Female115133.40Age(years)0--3112732.704--6154244.807--1477422.50Total3443100

Summary of the exposure measures and covariates {#Sec8}
-----------------------------------------------

The summary statistics of environmental variables were summarized in Table [2](#Tab2){ref-type="table"}. During the study period, the daily levels of PM~2.5~ ranged from 6 to 110 μg/m^3^ with an annual mean of 27.44 μg/m^3^. The mean PM~2.5~ concentration was 2.16% lower than the Grade II Annual PM~2.5~ Standard of CNAAQS (35 μg/m^3^), but 2.7 times higher than the annual average PM~2.5~(10 μg/m^3^) in WHO guideline. Daily levels of PM~10~ranged from 11 to 141 μg/m^3^ with an annual mean of 47.66 μg/m^3^. The exposure of PM~2.5~ for the cohort ranged from 0 to 7 days in one week before the exacerbation, and 0 to 14 days in two weeks before the exacerbation(Fig. [2](#Fig2){ref-type="fig"}). The exposure of PM~10~for the cohort ranged from 0 to 7 days in one week and 0 to 14 days in two weeks (Fig. [3](#Fig3){ref-type="fig"}). The average exposure to PM was 2 days in one week and 4 days in two weeks for PM~2.5~, and 3 days in one week and 6 days in two weeks for PM~10~.Table 2Overview of environmental variables in XiamenMeanSDMinimumFirst quartileMedianThird quartileMaximumPM~2.5~(μg/m^3^)27.4414.5356172435110PM~10~(μg/m^3^)47.6622.77911314360141Temperature(°C)21.306.223.915.9722.0527.1231Precipitation(mm)4.0712.760000.9172.7Wind speed(m/s)2.681222.53.29.6Fig. 2Distribution and exposure leveltoPM~2.5~. Panel(**a**): Distribution of exposure days of PM~2.5~ in one week before the exacerbation and the density curve;Panel(**b**): Distribution of exposure days of PM~2.5~ in two weeks before the exacerbation and the density curve; Panel(**c**): Exposure days of PM~2.5~ in one week (red line) and in two weeks (blue line) before the exacerbationFig. 3Distribution and exposure level to PM~10~.Panel (**a**): Distribution of exposure days of PM~10~ in one week before the exacerbation and the density curve; Panel(**b**): Distribution of exposure days of PM~10~ in two weeks before the exacerbation and the density curve; Panel(**c**): Exposure days of PM~10~ in one week (red line) and in two weeks (blue line) before the exacerbation

As for the weather conditions during the study period, the average daily temperature ranged from3.9--31 °C (annual average 21.3 °C) during the study period. The average precipitation ranged from 0 to 172.7 mm (annual average 4.07 mm). And the average wind speed ranged from 2 to 9.6 m/s (annual average 2.68 m/s).

PM exposure versusRisk of exacerbation {#Sec9}
--------------------------------------

The exposureto PM~2.5~ in one week (Standardized OR = 1.091; 95% CI: \[1.029, 1.157\]; *p* = 0.003) and two weeks (Standardized OR = 1.161; 95% CI: \[1.084, 1.243\];*p* \< 0.001) were both significantly associated with higher risk of asthma exacerbation (Fig. [4](#Fig4){ref-type="fig"}, Table [3](#Tab3){ref-type="table"}a). And the effect of PM~2.5~ exposure in two weeks was more severe than the exposure in one week.Fig. 4Odds ratiosof asthma exacerbation estimated for the exposure days to PM~2.5~ and PM~10~.Panel (**a**): Exposure days to PM~2.5~ within one week. Panel(**b**): Exposure days to PM~2.5~ within two weeks. Panel(**c**): Exposure to PM~10~ within one week. Panel(**d**): Exposure to PM~10~ within two weeksTable 3**a.** Odds ratios of asthma exacerbation for exposure days to PM~2.5~. **b.** Odds ratios of asthma exacerbation for exposure days toPM~10~VariableORStandardized OR%increaseStandardized 95%CI*P*-valueOne-week-modelPM~2.5~ Exposure (day)1.0471.0919.10\[1.029, 1.157\]0.003\*\*Temperature (°C)1.0091.0494.89\[0.994, 1.106\]0.079Precipitation(mm)1.0031.0201.96\[0.975, 1.066\]0.397Wind Speed(m/s)0.9430.966−3.44\[0.922, 1.011\]0.137Fever19.2872.401140.15\[2.208, 2.612\]\< 0.001\*\*\*Two-week-modelPM~2.5~ Exposure(day)1.0491.16116.06\[1.084, 1.243\]\< 0.001\*\*\*Temperature (°C)1.0221.12512.52\[1.056, 1.199\]\< 0.001\*\*\*Precipitation(mm)0.9970.984−1.57\[0.941, 1.030\]0.492Wind Speed(m/s)0.9580.979−2.08\[0.935, 1.025\]0.370Fever19.2912.402140.16\[2.208, 2.612\]\< 0.001\*\*\*One-week-modelPM~10~ Exposure(day)1.0311.0717.12\[1.013, 1.132\]0.015\*Temperature (°C)1.0061.0353.53\[0.984, 1.090\]0.184Precipitation(mm)1.0041.0242.40\[0.977, 1.073\]0.323Wind Speed(m/s)0.9180.950−5.01\[0.909, 0.992\]0.021\*Fever19.2912.402140.16\[2.208, 2.612\]\< 0.001\*\*\*Two-week-modelPM~10~ Exposure(day)1.0271.10610.64\[1.042, 1.175\]\< 0.001\*\*\*Temperature (°C)1.0141.0797.93\[1.020, 1.142\]0.008\*\*Precipitation(mm)0.9970.989−1.15\[0.943, 1.036\]0.633Wind Speed(m/s)0.9070.954−4.65\[0.913, 0.996\]0.033\*Fever19.2762.401140.11\[2.208, 2.611\]\< 0.001\*\*\*\**P* \< 0.05, \*\**P* \< 0.01, \*\*\* *P* \< 0.001

Just like PM~2.5~, PM~10~ exposure during one week and two weeks showed a significant increase in the risk of asthma attacks. Each incremental day of exposure increased the risk of asthma onset by 7.12% (*p* = 0.015; 95% CI: \[1.3, 13.2%\], in one week) and 10.64%(*p* \< 0.001; 95% CI: \[4.2, 17.5%\], in two weeks) (Table [3](#Tab3){ref-type="table"}b).

As for weather conditions, temperature and wind speed had significant effect on asthma exacerbation. Rise of temperature increased the risk of asthma exacerbation, and increase in wind speed reduced the risk of asthma exacerbation. When exposed to PM~2.5~, the standardized OR of the temperature during one week was 1.049 (*p* = 0.079). The standardized OR of the temperature during two weeks was 1.125 (*p* \< 0.001) (Table [3](#Tab3){ref-type="table"}a). When exposed to PM~10~, the standardized OR of the temperature during two weeks was 1.079 (*p* = 0.008) (Table [3](#Tab3){ref-type="table"}b). In addition, when exposed to PM~10~, the standardized OR of wind speed in one week was 0.950 (*p* = 0.021), and the standardized OR of wind speed in two weeks was 0.954 (*p* = 0.033) (Table [3](#Tab3){ref-type="table"}b).

Fever had a significant effect on asthma exacerbation. When exposed to PM~2.5~ for two weeks, the standardized OR of fever was 2.402 (*p* \< 0.001), and as for PM~10~, the standardized OR was 2.401 (*p* \< 0.001).

Association between PM exposure and disease control rate of childhood asthma {#Sec10}
----------------------------------------------------------------------------

During the whole period, the exposure of PM~2.5~ and PM~10~ was higher in winter and lower in summer, while the control rate peaked in summer and was the lowest in winter (Fig. [5](#Fig5){ref-type="fig"}a). With the increase of days of PM exposure, the control rate showed a downward trend (Fig. [5](#Fig5){ref-type="fig"}b).Fig. 5The association between PM exposure and DCR for childhood asthma. Panel (**a**):Time series of PM and DCR for childhood asthma during the study period. Panel (**b**): Distribution of PM exposure and DCR. PM~2.5~ (blue) and PM~10~ (red) were indicated

Among the 3443 returning patients, PM~2.5~exposure did not affect the control rate (*p* = 0.347, Fig. [6](#Fig6){ref-type="fig"}a, Table [4](#Tab4){ref-type="table"}),however exposure to PM~10~ had a negative effect on childhood asthma control rate (Fig. [6](#Fig6){ref-type="fig"}b, Table [4](#Tab4){ref-type="table"}),as each increasing day of exposure to PM~10~ reduced the odds of childhood asthma control by 15.18% (standardized OR 0.848;95%CI: \[0.786,0.915\], *p* \< 0.001). Fever was associated with the decrease of DCR (standardized OR of PM~2.5~ was 0.923 and standardized OR of PM~10~ was 0.924).Fig. 6Odds ratios of each increasing day of exposure to PM~2.5~(**a**) and PM~10~(**b**) on DCR of childhood asthmaTable 4Odds ratios of asthma control for exposure days toPM~2.5~ and PM~10~VariableORStandardized OR%increaseStandardized 95%CI*P*-valuePM~2.5~Exposure(day)0.9940.959− 4.10\[0.879, 1.046\]0.347Temperature (°C)1.041.25625.56\[1.155, 1.365\]\< 0.001\*\*\*Precipitation(mm)0.9880.962−3.84\[0.910, 1.015\]0.159Wind Speed(m/s)0.7270.883−11.72\[0.837, 0.931\]\< 0.001\*\*\*Fever0.7260.923−7.67\[0.876, 0.974\]0.003\*\*PM~10~Exposure(day)0.9760.848−15.18\[0.786, 0.915\]\< 0.001\*\*\*Temperature (°C)1.0261.1616.02\[1.079, 1.248\]\< 0.001\*\*\*Precipitation(mm)0.9790.934−6.62\[0.884, 0.987\]0.015Wind Speed(m/s)0.7430.891−10.95\[0.846, 0.938\]\< 0.001\*\*\*Fever0.7270.924−7.64\[0.876, 0.974\]0.003\*\*\**P* \< 0.05, \*\**P* \< 0.01, \*\*\* *P* \< 0.001

Discussion {#Sec11}
==========

Our study confirmed that the exposure to PM~2.5~and PM~10~ within one or two week sposed significant risk to exacerbation of childhood asthma in Xiamen, China. The risk of PM exposure was independent on the effects of other pollutants, weather conditions, or individual variation. In addition, our data suggested that the effect of exposure to PM lasted for at least weeks.

The association between PM exposure and the risk of asthma has been studied in different regions of the world and consensus have been reached that high exposure to PM causes increased risk of exacerbation and admission rate \[[@CR34]\]. For example, one study conducted in Seattle, Washington suggested that for every 11 μg/m3 increase in PM~2.5~ concentration, the OR of childhoodasthma was 1.15 (95% CI: 1.08 to 1.23) \[[@CR35]\]. An Australian survey which sampled 36,024 hospitalized patients with asthma showed that the impacts of PM~2.5~, NO~2~, PM~10~and pollen in the cold season on hospitalization for asthma were 30.2% (95% CI: 13.4 to 49.6%), 12.5% (95% CI: 6.6 to 18.7%), 8.3% (95% CI: 2.5 to 14.4%), and 4.2% (95% CI: 2.2\~6.1%), respectively \[[@CR36]\]. Taiwanese scholars used the open data of the government to investigate the air pollution in different urban models using time-stratified case crossover studies and conditional logistic regression analysis in 4237 hospitalized children with asthma in Taipei and Kaohsiung from 2001 to 2010 \[[@CR37]\]. The results showed that the risk of hospitalization for childhood asthma was significantly correlated with air pollutants. After being adjusted by season, the air pollution in Kaohsiung City had greater impact on the hospitalization of childhood asthma than that in Taipei.

Although many studies addressed the effects of PM exposure on asthma risk in the long-term \[[@CR17]\], less is known about the transient effects of PM exposure in the scale of weeks. Several recent studies address the effects of PM exposure on asthma exacerbation in short-term in Ningbo, Taipei, Seoul and Detroit \[[@CR38]--[@CR41]\]. According to these reports, the highest effect size of PM exposure on asthma exacerbation ranges from5 to 10 days. In order to accommodate the lagged effect we estimated the effect size for one week and two weeks of exposure, respectively. Our data confirm PM exposure as a risk factor to asthma exacerbation and the effect peaks at two weeks of exposure, which is consistent to prior studies. Moreover, our results suggest PM exposure has a negative effect on the disease control rate, which provided extra evidence for the hazardous impact of PM on childhood asthma. In an investigation of commuters, PM2.5 exposure was associated with lower FEV1% predicted among participants with below-median asthma control (3 h postcommute: -7.2 \[95% CI = − 11.8, − 2.7\]) \[[@CR42]\]. A study in El Paso, Texas showed positive associations between Asthma Control Questionnaire (ACQ) scores and 96-h effects of PM~10~, PM~2.5~, black carbon, NO2 and ozone. In this study, the ACQ was used to evaluate asthma control \[[@CR43]\]. Scottish scholars found that there is an exposure-response relationship between indoor PM~2.5~ concentration and poorer asthma control in children prescribed inhaled corticosteroids (ICS) \[[@CR44]\]. The effect of PM~2.5~ in this study is reported after 5 days of exposure.

Prior studies use different measures to quantify the level of exposure to PM \[[@CR39], [@CR40]\]. In this study, we used the "Technical Regulation on Ambient Air Quality Index" (AQI, HJ 633--2012) \[[@CR33]\] issued by Chinese government as an official standard classify air quality and use the total number of days of level 2 and 3 as a measure of exposure. The regional AQI is based on air-pollution measures from different sites and normalized for geological variations hence more accurate and comprehensive. In addition, the use of AQI makes our data directly applied to the regulation policies of pollution control and public health. There are other ways to measure the exposure to PM, such as the average concentration. Our results based on exposure days are consistent with and complementary to the prior studies.

PM exposure is not a stand-alone risk of asthma exacerbation. It has been previously shown that weather conditions, other environmental exposure, infections and self-management all contribute to the exacerbation of asthma. Our study is based on case-crossover design where each subject serves as its own control. Such a design can effectively remove inter-subject variations such as self-management. As for the weather conditions, temperature, barometric pressure and humidity are tightly correlated with each other, therefore, we kept only temperature to avoid collinearity. Co-morbid infections are not directly measured in the data we obtained but at the same time strongly affect the exacerbation of asthma. Therefore, we used surrogate variables such as the record of fever in the history of present illness.

To estimate the effect of PM exposure on DCR, we combine the uncontrolled and partly controlled subject into one group. The same classification is used in prior clinical studies of asthma exacerbation \[[@CR31], [@CR32]\]. Plus, around 20% of partly controlled asthma will develop into uncontrolled disease and has a risk of exacerbation (0.1%) \[[@CR45], [@CR46]\].

In spite of the growing concern over air pollution caused by PM, the hospitals and public health services in China still lack accurate regional assessment of the risk posed by PM exposure, which is required for risk management and preventative measures. The resultsofour study provided basis for preventative and clinical management of the exacerbation risk of asthma. In particular, we also described a method based on case-crossover design that can apply to other regions of the country.

Real-world evidence (RWE) has become increasingly important in medical and epidemiological research. Our study based on information extracted from local EHR database provides a plausible pipeline to address environmental risk factors using RWE, which enables more accurate estimate of the effects in large population. On the other hand, unknown bias factors can confound the analysis based on RWE, therefore we have considered all possible covariates. More importantly, the case-crossover design is based on self-control, thus, less affected by sampling biases.

Finally, the biological mechanism of the toxicity of PM is not fully elucidated inhuman. However, many studies confirm that the toxicity of PM is related to the immunogenicity and the consequential immune responses using cell line and animal model \[[@CR47]\]. In OVA-sensitized mice, exposure to PM promote the proliferation of peribronchial lymph nodes and the activation of T-help cell subtype 2 which provokes inflammation in airway \[[@CR48], [@CR49]\]. Other studies suggest exposure to PM result in an increment of both neutrophils and eosinophils \[[@CR50]\]; it also causes imbalance activities of Th1/Th2 through the activation of TNF- α and suppression of INF-γ \[[@CR51], [@CR52]\]. Moreover, prior studies also demonstrate that exposure to PM affect with the activities of monocytes and macrophages \[[@CR53]\]. A number of pathological changes, such as inflammatory cell infiltration, bronchial smooth muscle thickening, and bronchial mucosal injury are observed following the exposure to PM \[[@CR54]\]. More recent study shows that certain transcription factors, such as Toll-like receptor and nuclear factor-erythroid 2-ralated factor 2(Nrf2) signaling pathway are involved in the inflammatory responses in the airway of asthmatic mice \[[@CR55]\].

The physicochemical property of PM varies substantially due to the source of pollutant as well as climate. It is still not clear what is the exact molecular basis underlying the toxicity of PM. Our results are constrained to the local conditions in Xiamen and may differ from other regions due to the different chemical features of PM. To address the question, systematic chemical description of the PM is needed in future study.

Conclusions {#Sec12}
===========

This study assessed the short-term effects of air pollution and weather conditions on childhood asthma exacerbation and control rate in Xiamen. We confirmed that short-term exposure to PM for one or two weeks increased the risk of exacerbation in asthmatic children and compromises the disease control rate. Our study provides epidemiological data for formulating environmental health policy and clinical prevention of asthma in children. Our findings reaffirmed the necessity of preventive care for asthma susceptible population according to environmental conditions.
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